Hypothetical Demand Curve and Price for the COVID-19 Vaccine

• Autorzy: Anita Kolnhofer-Derecskei , Gyöngyi Csongrádi , Arnold Tóth , György Hauber
• Języki publikacji: EN

Abstrakty

EN

This research aims to study the demand for a COVID-19 vaccine. The main objective of this research was to investigate the willingness to pay (WTP) of those people who are eligible for the government-financed vaccination programme under which this medication is available free of charge. Based on this, the study aimed to assess the optimum price that people are willing to pay for the vaccine. More than 300 undergraduate students were questioned in classroom experiments about their personal preferences in order to derive the demand curve for a hypothetical market for the COVID-19 vaccine. A regression analysis of the results showed that the linear and power functions could describe consumer behaviour and predict an optimal market price for the investigated item. In addition, the linear model fitted better. Finally, we compared our result with the real prices of the various vaccines available on the market to see if the predicted price was viable under the prevailing market conditions. The optimal price informs us how many people will receive the next vaccine if it is offered at a specific market price. It also informs us what price the government should assign to the vaccine to secure a particular target vaccination rate. (original abstract)

Słowa kluczowe

EN

Demand analysis; Willingness to pay (WTP); COVID-19; Pricing theory

PL

Analiza popytu; Metoda gotowości do płacenia; COVID-19; Teoria cen

• Czasopismo: Forum Scientiae Oeconomia
• Rocznik: 2022
• Tom: 10
• Numer: nr 4
• Strony: 175--197

Twórcy

autor

Anita Kolnhofer-Derecskei

• Budapest Business School, Hungary

autor

Gyöngyi Csongrádi

• Budapest Business School, Hungary

autor

Arnold Tóth

• Budapest Business School, Hungary

autor

György Hauber

• Budapest Business School, Hungary

Bibliografia

• Ahmetoglu, G., Furnham, A., Fagan, P. (2014), Pricing practices: A critical review of their effects on consumer perceptions and behaviour, Journal of Retailing and Consumer Services, 21(5), 696-707. DOI: 10.1016/j.jretconser.2014.04.013.
• Ariely, D. (2010), Predictably Irrational: The Hidden Forces That Shape Our Decisions, New York: Harper Collins.
• Aviva, A., Einav, L., Finkelstein, A. (2013), The RAND Health Insurance Experiment, Three Decades Later, Journal of Economic Perspectives, 27(1), 197-222. DOI: 10.1257/jep.27.1.197.
• Ballance, R., Pogány, J., Forstner, H. (1992), The World's Pharmaceutical Industries, Aldershot: Edward Elgar Publishing Ltd.
• Berghea, F., Berghea, C.E., Abobului, M., Vlad, V.M. (2020), Willingness to pay for a for a potential vaccine against SARS-CoV-2/COVID-19 among adult persons, Human Vaccines & Immunotherapeutics 16(12), 3074-3080. DOI: 10.21203/rs.3.rs-32595/v1.
• Berns, G.S. (2005), Price, Placebo, and the Brain, Journal of Marketing Research, 42(4), 399-400. DOI: 10.1509/jmkr.2005.42.4.399.
• Bolton, L.E., Alba, J.W. (2006), Price Fairness: Good and Service Differences and the Role of Vendor Costs, Journal of Consumer Research, 33, 258-265. DOI: 10.1086/506306.
• Borenstein, S. (1985), Price Discrimination in Free-Entry Markets, The RAND Journal of Economics, 16(3), 380-397. DOI: 10.2307/2555565.
• Borriello, A., Master, D., Pellegrini, A., Rose, J.M. (2021), Preferences for a COVID-19 vaccine in Australia, Vaccine, 39(3), 473-479. DOI: 10.1016/j.vaccine.2020.12.032.
• Brown, T.C. (2005), Loss aversion without the endowment effect, and other explanations for the WTA-WTP disparity, Journal of Economic Behavior & Organization, 57(3), 367-379. DOI: 10.1016/j.jebo.2003.10.010.
• Cabrales, A., Jiménez-Martín, S. (2013), The determinants of pricing in pharmaceuticals: are US prices really so high?, Health economics, 22(11), 1377-1397. DOI: 10.1002/hec.2887.
• Cardella, G.M., Hernández-Sánchez, B.R., Sánchez-García, J.C. (2021), Development and validation of a scale to evaluate students' future impact perception related to the coronavirus pandemic (C-19FIPS), PloS ONE, 16(11), e0260248. DOI: 10.1371/journal.pone.0260248.
• Carpio, C.E., Coman, I.A., Sarasty, O., Gracía, M. (2021), COVID-19 vaccine demand and financial incentives, Applied Health Economics and Health Policy, 19(6), 871-883. DOI: 10.1007/s40258-021-00687-9.
• Cascini, F., Pantovic, A., Al-Ajlouni, Y., Failla, G., Ricciardi, W. (2021), Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review, EClinicalMedicine, 40, 101113. DOI: 10.1016/j.eclinm.2021.101113.
• Catma, S., Varol, S. (2021), Willingness to pay for a hypothetical COVID-19 vaccine in the United States: A contingent valuation approach, Vaccines, 9(4), 318. DOI: 10.3390/vaccines9040318.
• Cerda, A.A., Leidy Y.G. (2021), Willingness to pay for a COVID-19 vaccine, Applied Health Economics and Health Policy, 19(3), 343-351. DOI: 10.1007/s40258-021-00644-6.
• Chernew, M., Gibson, T.B., Yu-Isenberg, K., Sokol, M.C., Rosen, A.B., Fendrick, A.M. (2008), Effects of increased patient cost sharing on socioeconomic disparities in health care, Journal of General Internal Medicine, 23(8), 1131-1136. DOI: 10.1007/s11606-008-0614-0.
• Danzon, P.M., Chao, L.W. (2000), Does regulation drive out competition in pharmaceutical markets?, Journal of Law and Economics, 43, 311-357. DOI: 10.1086/467458.
• Dias-Godói, I.P., Tadeu Rocha Sarmento, T., Afonso Reis, E., Peres Gargano, L., Godman, B., de Assis Acurcio, F., Alvares-Teodoro, J., Guerra Júnior, A.A., Mariano Ruas, C. (2022), Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: A cross-sectional study and the implications, Expert Review of Pharmacoeconomics & Outcomes Research, 22(1), 119-129. DOI: 10.1080/14737167.2021.1931128.
• Druckman, J.N., Kam, C.D. (2009), Students as experimental participants: A defense of the "Narrow Data Base.". DOI: 10.2139/ssrn.1498843.
• Ellis, R.P., Martins, B., Zhu, W. (2017), Health care demand elasticities by type of service, Journal of Health Economics, 55, 232-243. DOI: 10.1016/j.jhealeco.2017.07.007.
• Ellison, S.F., Cockburn, I., Griliches, Z., Hausman, J. (1997), Characteristics of demand for pharmaceutical products: An examination of four cephalosporins, The Rand Journal Of Economics, 28(3), 426-446. DOI: 10.2307/2556023.
• Fibich, G., Gavious, A., Lowengart, O. (2005), The dynamics of price elasticity of demand in the presence of reference price effects, Journal of the Academy of Marketing Science, 33(1), 66-78. DOI: 10.1177/0092070304267108.
• Friedman, M. (2007), Price Theory, London: Routledge.
• Ganuza, J.-J., Llobet, G., Domínguez, B. (2009), R&D in the pharmaceutical industry: A world of small innovations, Management Science, 55(4), 539-551. http://www.jstor.org/stable/40539168.
• Georgantzís, N., Navarro-Martínez, D. (2010), Understanding the WTA-WTP gap: Attitudes, feelings, uncertainty and personality, Journal of Economic Psychology, 31(6), 895-907. DOI: 10.1016/j.joep.2010.07.004.
• Han, K., Francis, M. R., Zhang, R., Wang, Q., Xia, A., Lu, L., Yang, B., Hou, Z. (2021), Confidence, acceptance and willingness to pay for the COVID-19 vaccine among migrants in Shanghai, China: A cross-sectional study, Vaccines, 9(5), 443, DOI: 10.3390/vaccines9050443.
• Holmes, E.A., O'Connor, R.C., Perry, V.H., Tracey, I., Wessely, S., Arseneault, L., Ballard, C., Christensen, H., Cohen Silver, R., Everall, I., Ford, T., John, A., Kabir, T., King, K., Madan, I., Michie, S., Przybylski, A.K., Shafran, R., Sweeney, A., Worthman, C. M., Bullmore, E. (2020), Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science, The Lancet Psychiatry, 7(6), 547-560. DOI: 10.1016/S2215-0366(20)30168-1.
• Holt, C.A. (2019), Markets, Games and Strategic Behavior: An Introduction to Experimental Economics (2nd edition.), Princeton, NJ: Princeton University Press.
• Horowitz, J.K., McConnell, K.E. (2002), A review of WTA/WTP studies, Journal of Environmental Economics and Management, 44(3), 426-447. DOI: 10.1006/jeem.2001.1215.
• Huang, J., Leng, M., Parlar, M. (2013), Demand functions in decision modeling: A comprehensive survey and research directions, Decision Sciences, 44(3), 557-609. DOI: 10.1111/deci.12021.
• Hursh, S.R., Silberberg, A. (2008), Economic demand and essential value, Psychological Review, 115(1), 186-198. DOI: 10.1037/0033-295X.115.1.186.
• Hursh, S.R., Winger, G. (1995), Normalized demand for drugs and other reinforcers, Journal of the Experimental Analysis of Behavior, 64(3), 373-384. DOI: 10.1901/jeab.1995.64-373.
• Iyer, G., Nandur, V., Soberman, D. (2022), Vaccine hesitancy and monetary incentives, Humanities Social Sciences Communications, 9, 81. DOI: 10.1057/s41599-022-01074-y.
• Jensen, R.T., Miller, N.H. (2008), Giffen behavior and subsistence consumption, American Economic Review, 98(4), 1553-1577. DOI: 10.1257/aer.98.4.1553.
• Kabir, M., Mondal, M., Eliyas, M., Mannan, M.A., Hashem, M., Debnath, N., Miazi, O., Mohiuddin, C., Kashem, M., Islam, M., Elahi, M. (2011), An epidemiological survey on investigation of tick infestation in cattle at Chittagong District, Bangladesh, African Journal of Microbiology Research, 5(4), 346-352. DOI: 10.5897/AJMR10.706.
• Kahneman, D., Tversky, A. (1979), Prospect theory: An analysis of decision under risk, Econometrica, 47, 263-291. DOI: 10.1142/9789814417358_0006.
• Kálmán, B., Bárczi, J., Zéman, Z. (2021), Financial knowledge of higher education students of economics, in: Z. Pál, Y. Serpeninova and L. Hrytsenko (Eds.), Aspects of Financial Literacy: Proceedings of the International Scientific and Practical Conference March 22-23 (pp. 176-191), Sumy State University.
• Kaźmierska-Jóźwiak, B., Sekula, P., Socha, B. (2021), Analysis of the effects of COVID-19 on companies listed on the Warsaw Stock Exchange, Forum Scientiae Oeconomia, 9(4), 99-116. DOI: 10.23762/FSO_VOL9_NO4_5.
• Kitukutha, N., Vasa, L., Oláh, J. (2021), The impact of COVID-19 on the economy and sustainable e-commerce, Forum Scientiae Oeconomia, 9(2), 47-72. DOI: 10.23762/FSO_VOL9_NO2_3.
• Klein, P.A. (1973), Demand theory and the economist's propensity to assume, Journal of Economic Issues, 7(2), 209-239. http://www.jstor.org/stable/4224224.
• Kolnhofer-Derecskei, A., Csongrádi, G. (2022), How do the framing effects, environmental factors and personal risk perceptions influence our decision about a hypothetical COVID-19 pill?, Journal of Decision Systems. DOI: 10.1080/12460125.2022.2085854.
• Kolnhofer-Derecskei, A. (2020), How much can a beer cost in a fancy resort hotel? The possible replication of Thaler's well-known experiment, in: W. Sroka (Ed.), Perspectives on Consumer Behaviour. Theoretical Aspects and Practical Applications (pp. 241-257), Cham: Springer. DOI: 10.1007/978-3-030-47380-8_11.
• Kolnhofer-Derecskei, A., Csongrádi, G., Tóth, A. (2022), Hogyan befolyásolja a keretbe foglalási hatás a fizetési hajlandóságot egy újonnan bevezetendő COVID-19 gyógyszer esetén?, Gradus, 9(1), 1-9. DOI: 10.47833/2022.1.ECO.001. (Original work published in Hungarian).
• Kozlovskyi, S., Daria Bilenko, D., Kuzheliev, M., Ivanyuta, N., Butenko, V., Lavrov, R. (2021), Comparison and assessment of factors affecting the COVID-19 vaccination in European countries, Problemy Ekorozwoju-Problems of Sustainable Development, 16(2), 26-33. DOI: 10.35784/pe.2021.2.03.
• Kyle, M. (2007), Pharmaceutical Price controls and entry strategy, Review of Economics and Statistics, 89(1), 88-99. DOI: 10.1162/rest.89.1.88.
• Lázár, E. (2009), New methods in demand based price optimization, Journal of Economics and Business Research, XV(2), 43-63.
• Lázár, E. (2010), Microeconometric models in market research price optimization, Journal of Economics and Business Research, XVI(1), 47-59.
• Lázár, E. (2011), Ároptimalizálás, ökonometriai modellezésen és az empirikus keresleti függvény meghatározásán alapuló árazási technikák, Vezetéstudomány 42(6), 68-56. DOI: 10.14267/VEZTUD.2011.06.06. (Original work published in Hungarian).
• Lichtenstein, D.R., Bloch, P.H., Black, W.C. (1988), Correlates of price acceptability, Journal of Consumer Research, 15(2), 243-252. DOI: 10.1086/209161.
• Light, D.W., Lexchin, J. (2021), The costs of coronavirus vaccines and their pricing, Journal of the Royal Society of Medicine, 114(11), 502-504. https://doi:10.1177/01410768211053006.
• Lin, Y., Hu, Z., Zhao, Q., Alias, H., Danaee, M., Wong, L.P. (2020), Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China, PLoS Neglected Tropical Diseases, 14(12), e0008961. DOI: 10.1371/journal.pntd.0008961.
• Liu, S., Liu, J. (2021), Understanding behavioral intentions toward COVID-19 vaccines: Theorybased content analysis of tweets, Journal of Medical Internet Research, 23(5), e28118. DOI: 10.2196/28118.
• Lu, Z.J., Comanor, W.S. (1998), Strategic pricing of new pharmaceuticals, The Review of Economics and Statistics, 80(1), 108-118. http://www.jstor.org/stable/2646733.
• Mankiw, G. (2011), Principles of Economics, Cincinnati, OH: South-Western College Pub.
• Marshall, A. (1906), Letter to A.L. Bowley, in: D.L. Sills and R.K. Merton, R.K. (Eds.) Social Science Quotations: Who Said What, When, and Where (p. 151), Transaction Publishers.
• Martonosi, S.E., Behzad, B., Cummings, K. (2021), Pricing the COVID-19 vaccine: A mathematical approach, Omega, 103, 102451. https://doi:10.1016/j.omega.2021.102451.
• McDougall, J.A., Furnback, W.E., Wang, B.C.M., Mahlich, J. (2020), Understanding the global measurement of willingness to pay in health, Journal of Market Access & Health Policy, 8(1). DOI: 10.1080/20016689.2020.1717030.
• Miller, K.M., Hofstetter, R., Krohmer, H., Zhang, Z.J. (2011), How should consumers' willingness to pay be measured? An empirical comparison of state-of-the-art approaches, Journal of Marketing Research, 48(1), 172-184.
• Miniszterelnöki Kabinetiroda. (2021), 5 millió 947 ezer beoltott, 4039 az új fertőzött, elhunyt 45 beteg, retrieved from: https://koronavirus.gov.hu/cikkek/5-millio-947-ezer-beoltott-4039-az-uj-fertozott-elhunyt-45-beteg. (accessed 15 February 2022). (Original work published in Hungarian).
• MNB. (2021a), Exchange rate, retrieved from: http://www.mnbkozeparfolyam.hu/arfolyam-2021-10.html. (accessed 20 May 2022).
• MNB. (2021b), Inflation, retrieved from: https://www.mnb.hu/letoltes/inflacios-folyamatok-ertekelese-hu-2021-oktober.pdf. (accessed May 20, 2022)
• Morrison, G.C. (1998), Understanding the disparity between WTP and WTA: Endowment effect, substitutability, or imprecise preferences?, Economics Letters, 59(2), 189-194. DOI: 10.1016/S0165-1765(98)00049-4.
• Newman, M., Ferrario, C.R. (2020), An improved demand curve for analysis of food or drug consumption in behavioral experiments, Psychopharmacology, 237(4): 943-955. DOI: 10.1007/s00213-020-05491-2.
• Peng L., Jiang H., Guo Y., Hu, D. (2022), Effect of information framing on wearing masks during the COVID-19 pandemic: Interaction with social norms and information credibility front, Public Health, 10, 811792. DOI: 10.3389/fpubh.2022.811792.
• Plassmann, H., Weber, B. (2015), Individual differences in marketing placebo effects: Evidence from brain imaging and behavioral experiments, Journal of Marketing Research, 52(4), 493-510. DOI: 10.1509/jmr.13.0613.
• Sarasty, O., Carpio, C.E., Hudson, D., Guerrero-Ochoa, P.A., Borja, I. (2020), The demand for a COVID-19 vaccine in Ecuador, Vaccine, 38(51), 8090-8098. DOI: 10.1016%2Fj.vaccine.2020.11.013.
• Sasaki S., Saito T., Ohtake F. (2022), Nudges for COVID-19 voluntary vaccination: How to explain peer information?, Social, Science Social Science & Medicine, 292(2022), 114561, DOI: 10.1016/j.socscimed.2021.114561.
• Scherer, F.M. (2000), The Pharmaceutical Industry, in: A. Culyer, J. Newhouse (Eds.), Handbook of Health Economics (pp. 1297-336), New York: Elsevier.
• Schweitzer, S.O., Lu, Z.J. (2018), Pharmaceutical economics and policy, Oxford: Oxford University Press.
• Shampanier, K., Mazar, N., Ariely, D. (2007), Zero as a special price: The true value of free products, Marketing Science, 26(6), 742-757. https://doi.org10.1287/mksc.1060.0254.
• Shiv, B., Carmon, Z., Ariely, D. (2005), Placebo effects of marketing actions: Consumers may get what they pay for, MIT Sloan Research Paper No. 4533-05. http://dx.doi.org/10.2139/ssrn.707541.
• Shpak, N., Podolchak, N., Karkovska, V., Sroka, W., Horbal, N. (2022), The application of tools for assessing the financial security of enterprises, Forum Scientiae Oeconomia, 10(2), 29-44. DOI: 10.23762/FSO_VOL10_NO2_2.
• Sprengholz, P., Betsch, C. (2021), Comment on: "Willingness to pay for a COVID-19 vaccine", Applied Health Economics and Health Policy, 19(4), 619-621. DOI: 10.1007%2Fs40258-021-00656-2.
• Sroka, W. (Ed.) (2020), Perspectives on consumer behaviour: Theoretical aspects and practical applications, Cham: Springer.
• Steckel, J., Shampanier, K., O'Laughlin, L., Shea, J., Fair R.K. (2017), What Consumers Really Think About Reference Price Labels, Analysis Group Inc.
• Strickland, J.C., Reed, D.D., Hursh, S.R., Schwartz, L.P., Foster, R.N.S., Gelino, B.W., LeComte, R.S., Oda, F.S., Salzer, A.R., Schneider, T.D., Dayton, L., Latkin, C., Johnson, M. W. (2022), Behavioral economic methods to inform infectious disease response: Prevention, testing, and vaccination in the COVID-19 pandemic, PLoS ONE, 17(1), e0258828. DOI: 10.1371/journal.pone.0258828.
• Sun, S. (2020), An alternative approach for demand estimation. http://dx.doi.org/10.2139/ssrn.3550415.
• Terry, M. (2021), Comparing COVID-19 vaccines: Timelines, types and prices, Biospace, Retrieved from https://www.biospace.com/article/comparing-covid-19-vaccines-pfizer-biontech-moderna-astrazeneca-oxford-j-and-j-russia-s-sputnik-v/ (accessed 25 May 2022).
• Thaler, R. (1983), Transaction utility theory, Advances in Consumer Research, 10, 229-232.
• Thaler, R., Schafir, E. (2006), Invest now, drink later, spend never: On the mental accounting of delayed consumption, Journal of Economic Psychology, 27, 694-712. DOI: 10.1016/j.joep.2006.05.008.
• Tsutsui, Y., Shahrabani, S., Yamamura, E., Hayashi, R., Kohsaka, Y., Ohtake, F. (2021), The willingness to pay for a hypothetical vaccine for the coronavirus disease 2019 (COVID-19), International Journal of Environmental Research and Public Health, 18(23), 12450. DOI: 10.3390%2Fijerph182312450.
• UNICEF (2021), COVID-19 Vaccine Market Dashboard, retrieved from: https://www.unicef.org/supply/covid-19-vaccine-market-dashboard (accessed 10 May 2022).
• Vassilopoulos, A., Avgeraki, N., Klonaris, S. (2020), Social desirability and the WTP-WTA disparity in common goods, Environment Development and Sustainability, 22, 6425-6444. DOI: 10.1007/s10668-019-00490-6
• Wale-Awe, O., Sulaiman, L. (2020), Premium motor spirit (PMS) pricing and inflationary dynamics in Nigeria, Forum Scientiae Oeconomia, 8(3), 49-60. DOI: 10.23762/FSO_VOL8_NO3_3.
• Wang, J., Lyu, Y., Zhang, H., Jing, R., Lai, X., Feng, H., Fang, H. (2021), Willingness to pay and financing preferences for COVID-19 vaccination in China, Vaccine, 39(14), 1968-1976. DOI: 10.1016/j.vaccine.2021.02.060.
• Wee, S.L., Novak, B. (2021), Hungary pays big for a Chinese vaccine. The New York Times, retrieved from: https://www.nytimes.com/2021/03/12/world/hungar y-sinopharm-covid.html (accessed 21 April 2022).
• Whynes, D.K., Sach, T.H. (2007), WTP and WTA: Do people think differently?, Social Science & Medicine, 65(5), 946-957. DOI: 10.1016/j.socscimed.2007.04.014.
• Wong, L.P., Alias, H., Wong, P.F., Lee, H.Y., AbuBakar, S. (2020), The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay, Human Vaccines & Immunotherapeutics, 16(9), 2204-2214. DOI: 10.1080/21645515.2020.1790279.
• Yamoah, F., Haque, A. (2022), Strategic management through digital platforms for remote working in the higher education industry during and after the COVID-19 pandemic, Forum Scientiae Oeconomia, 10(2), 111-128. DOI: 10.23762/FSO_VOL10_NO2_6
• Zhang, Y., Luo, X., Ma, Z.F. (2021), Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: A nationally representative survey in mainland China, Human Vaccines & Immunotherapeutics, 17(6), 1622-1627. DOI: 10.1080%2F21645515.2020.1847585.
• Zhao, J. Kling, C.L. (2001), A new explanation for the WTP/WTA disparity, Economics Letters, 73(3), 293-300. DOI: 10.1016/S0165-1765(01)00511-0.

Identyfikatory

DOI

https://doi.org/10.23762/FSO_VOL10_NO4_9